In pancreatic cancer IL-1 secretion by tumor cells has been shown to constitutively activate NF-κB and to increase expression of downstream genes involved in the metastatic cascade [29, 30] and chemoresistance [31]. The gene discussed is IL1A; the disease is neoplasm.